Rudnik-Schöneborn S, Hausmanowa-Petrusewicz I, Borkowska J, Zerres K
Institute for Human Genetics, Technical University of Aachen, Germany.
Eur Neurol. 2001;45(3):174-81. doi: 10.1159/000052118.
Proximal spinal muscular atrophy (SMA) is classified into three main subtypes (I-III), defined by age at onset and achieved motor milestones. As age at onset can be very early in SMA II and III (IIIa, onset < 3 years) and does not necessarily correlate with prognosis, the question arises whether the child can be correctly assigned to a specific SMA type at the time of presentation based on the assessment of motor function. Therefore we studied the motor milestones in 175 SMA type II and 266 SMA type III patients. In SMA II, 73% of the patients sat within the normal age range (up to 9 months), the remainder learned to do so at ages between 10 and 30 months. In SMA III, the walking milestone was passed with delay (given an upper normal limit of 18 months) in 10% of all and 16% of SMA IIIa patients (median age 13 months, range 9-53 months). There was a correlation between late sitting and walking in SMA III, since those who sat after 9 months were responsible for the majority of delayed walkers. The median age when becoming chairbound did not differ between early-onset SMA III patients who walked with delay and those who walked within the normal age range (10.2 versus 10.5 years). In conclusion, a significant proportion of patients with early-onset SMA classified as SMA II on the basis of achieved motor function turned out to be SMA III at later follow-up. It is important to reassess a child in the first 2-4 years, to determine whether walking can be achieved with or without aids, as children who start to walk late have a similar favourable outcome for ambulation compared to earlier walkers.
近端脊髓性肌萎缩症(SMA)主要分为三种亚型(I - III型),根据发病年龄和所达到的运动发育里程碑来定义。由于SMA II型和III型(IIIa型,发病年龄<3岁)的发病年龄可能非常早,且不一定与预后相关,因此出现了一个问题,即根据运动功能评估,在就诊时能否将患儿正确地归为特定的SMA类型。因此,我们研究了175例SMA II型患者和266例SMA III型患者的运动发育里程碑。在SMA II型患者中,73%在正常年龄范围内(至9个月)学会坐立,其余患者在10至30个月之间学会坐立。在SMA III型患者中,所有患者中有10%、SMA IIIa型患者中有16%(中位年龄13个月,范围9 - 53个月)行走里程碑延迟(正常上限为18个月)。在SMA III型患者中,坐立延迟与行走延迟之间存在相关性,因为9个月后才学会坐立的患者占行走延迟患者的大多数。早发型SMA III型患者中行走延迟者和正常年龄范围内行走者出现需要依赖轮椅的中位年龄没有差异(分别为10.2岁和10.5岁)。总之,很大一部分基于所达到的运动功能被归类为SMA II型的早发型SMA患者在后续随访中被证实为SMA III型。在患儿2至4岁时重新评估很重要,以确定其能否在有或没有辅助的情况下行走,因为开始行走较晚的儿童与较早行走的儿童相比,在行走方面有相似的良好预后。